US4882332A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives
Assignee: Merck Sharp & Dohme LLC
•
Filing: 1986-10-20
•
Granted: 1989-11-21
•
Expires: 2006-10-20
Abstract
Abstract A method and composition for suppressing the immune response are disclosed which employ an immunosuppressing effective amount of certain aryl-substituted naphthyridines and pyrido-pyrazines.
Inventors
- 👤 Marvin I. Siegel
- 👤 Sidney R. Smith
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 15:53
CPC Classifications
C; C07; C07D; C07D471/00; C07D471/12; C07D471/14; C07D471/02; C07D471/04; C07D495/00; C07D495/12; C07D495/14
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
392 words
A method for suppressing T cell functions of the immune response in a mammal which comprises administering to a mammal in need of such treatment an immunosuppressing effective amount of a compound having the structural formula I ##STR21## or a pharmaceutically acceptable salt or solvate thereof, wherein: X represents CH or N; A represents O or S, m is an integer of from 0 to 2; n is an integer of from 0 to 2; R 1 and R 2 are the same or different and each is independently selected from H or alkyl containing 1 to 6 carbon atoms; W represents --O-- or --S(O) p --, wherein p is an integer of from 0 to 2; B represents alkylene having from 2 to 8 carbon atoms, which alkylene may be optionally substituted with a group selected from --OH, --F, alkyl having 1 to 4 carbon atoms, --CH 2 OH, --CHO, --CO 2 H, --COR 3 wherein R 3 is selected from --NHR 4 , --N(R 4 ) 2 or --OR 4 wherein R 4 is alkyl of 1 to 6 carbon atoms or --CN, with the proviso that OH or F is not on the carbon atom adjacent to W; Q represents an aryl group containing from 6 to 15 carbon atoms or an aromatic heterocyclic group containing from 3 to 14 carbon atoms and having at least one O, S or N in the ring, which aryl or aromatic heterocyclic group can optionally be substituted with up to 3 substituents Y as defined below; and each Y substituent is independently selected from --OH, hydroxymethyl, alkyl containing from 1 to 6 carbon atoms, halo, --NO 2 , alkoxy containing 1 to 6 carbon atoms, --CF 3 , --CN, cycloalkyl containing 3 to 7 carbon atoms, alkenyloxy containing from 3 to 6 carbon atoms, alkynyloxy containing from 3 to 6 carbon atoms, --S(O) p --R 4 wherein R 4 and p are as defind above, --CO--R 5 wherein R 5 represents --OH, --NH 2 , --NHR 4 , --N(R 4 ) 2 or --OR 4 in which R 4 is as defined above, --O--D--COR 5 wherein D represents alkylene having from 1 to 4 carbon atoms and R 5 is as defined above, --NH 2 , --NHR 4 , --N(R 4 ) 2 wherein R 4 is as defined above or --NHCOH.
Claim 2
Independent Claim
392 words
A method for suppressing T cell functions of the immune response in a mammal which comprises administering to a mammal in need of such treatment an immunosuppressing effective amount of a compound having the structural formula I ##STR21## or a pharmaceutically acceptable salt or solvate thereof, wherein: X represents CH or N; A represents O or S, m is an integer of from 0 to 2; n is an integer of from 0 to 2; R 1 and R 2 are the same or different and each is independently selected from H or alkyl containing 1 to 6 carbon atoms; W represents --O-- or --S(O) p --, wherein p is an integer of from 0 to 2; B represents alkylene having from 2 to 8 carbon atoms, which alkylene may be optionally substituted with a group selected from --OH, --F, alkyl having 1 to 4 carbon atoms, --CH 2 OH, --CHO, --CO 2 H, --COR 3 wherein R 3 is selected from --NHR 4 , --N(R 4 ) 2 or --OR 4 wherein R 4 is alkyl of 1 to 6 carbon atoms or --CN, with the proviso that OH or F is not on the carbon atom adjacent to W; Q represents an aryl group containing from 6 to 15 carbon atoms or an aromatic heterocyclic group containing from 3 to 14 carbon atoms and having at least one O, S or N in the ring, which aryl or aromatic heterocyclic group can optionally be substituted with up to 3 substituents Y as defined below; and each Y substituent is independently selected from --OH, hydroxymethyl, alkyl containing from 1 to 6 carbon atoms, halo, --NO 2 , alkoxy containing 1 to 6 carbon atoms, --CF 3 , --CN, cycloalkyl containing 3 to 7 carbon atoms, alkenyloxy containing from 3 to 6 carbon atoms, alkynyloxy containing from 3 to 6 carbon atoms, --S(O) p --R 4 wherein R 4 and p are as defind above, --CO--R 5 wherein R 5 represents --OH, --NH 2 , --NHR 4 , --N(R 4 ) 2 or --OR 4 in which R 4 is as defined above, --O--D--COR 5 wherein D represents alkylene having from 1 to 4 carbon atoms and R 5 is as defined above, --NH 2 , --NHR 4 , --N(R 4 ) 2 wherein R 4 is as defined above or --NHCOH.
Claim 3
Dependent Claim
13 words
A method according to claim 1 wherein W in formula I is oxygen.
Claim 4
Dependent Claim
13 words
A method according to claim 2 wherein A in formula I is oxygen.
Claim 5
Dependent Claim
13 words
A method according to claim 3 wherein X in formula I represents CH.
Claim 6
Dependent Claim
25 words
A method according to claim 4 wherein --B--W-- in formula I represents an alkyleneoxy group of which may be substituted as defined in claim 1.
Claim 7
Dependent Claim
23 words
A method according to claim 5 wherein --B--W-- in formula I represents --(CH 2 ) 4 --O-- or --(CH 2 ) 3 --O--.
Claim 8
Dependent Claim
13 words
A method according to claim 5 wherein m in formula I equals zero.
Claim 9
Dependent Claim
13 words
A method according to claim 7 wherein n in formula I equals zero.
Claim 10
Dependent Claim
16 words
A method according to claim 8 wherein Q in formula I represents phenyl or substituted phenyl.
Claim 11
Dependent Claim
27 words
A method according to claim 9 wherein the one to three Y substituents on the Q phenyl group are each independently selected from chloro, nitro or trifluoromethyl.
Claim 12
Dependent Claim
51 words
A method according to claim 1 wherein the compound administered has the formula II ##STR22## wherein A, B, W, Y and n are as defined in claim 1 and q is 0 to 2, and wherein, if n+q is greater than 1, the Y groups may be the same or different.
Claim 13
Dependent Claim
14 words
A method according to claim 1 wherein the compound administered is selected from 7-phenyl-1,2,3,4-tetrahydro-oxepino[2,3-c]-[1,8]-naphthyridin-6(7H)-one.
Claim 14
Dependent Claim
5 words
3-dihydro-6-phenyl-1H-pyrano[2,3-c][1,8]-naphthyridin-5(6H)-one; or 1,2-dihydro-5-phenylfuro[2,3-c][1,8]-naphthyridin-4-one; or 1,2-dihydro-2-(hydroxymethyl)-4-phenylcyclobuta(c)[1,8]naphthyridin-3(4H)-one.
Claim 15
Dependent Claim
5 words
3-dihydro-6-phenyl-1H-pyrano[2,3-c][1,8]-naphthyridin-5(6H)-one; or 1,2-dihydro-5-phenylfuro[2,3-c][1,8]-naphthyridin-4-one; or 1,2-dihydro-2-(hydroxymethyl)-4-phenylcyclobuta(c)[1,8]naphthyridin-3(4H)-one.
Claim 16
Dependent Claim
12 words
A method according to claim 1 wherein the compound administered comprises 7-(3-chlorophenyl)-1,2,3,4-tetrahydro-oxepino[2,3-c][1,8]-naphthyridin-6(7H)-one.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-11-20 | 1993-05-22 | 1993-11-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-11-20 | 1997-05-22 | 1997-11-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-11-20 | 2001-05-22 | 2001-11-21 | $7700.00 | Window Closed / Lapsed |